Iovance Biotherapeutics (IOVA) Revenue (2023 - 2026)
Iovance Biotherapeutics' Revenue came in at $99.31 million for Q2 2026, up 65.7% from $59.95 million a year earlier and up 39.0% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Revenue (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Iovance Biotherapeutics reported Revenue of $324.97 million, up 34.5% year-over-year; for FY2025, it was $263.5 million, up 60.6% from FY2024.
- Going back by year, Revenue was $164.07 million in FY2024 and $1.19 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q2 2023.
- Year-over-year, Revenue has increased for five consecutive quarters, with growth averaging 47.2% over the last five quarters.
- Business Quant data shows IOVA's Revenue at $71.43 million (Q1 2026), $86.77 million (Q4 2025) and $67.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | 99.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.31 Mn |
| Mar 31, 2026 | 71.43 Mn |
| Dec 31, 2025 | 86.77 Mn |
| Sep 30, 2025 | 67.46 Mn |
| Jun 30, 2025 | 59.95 Mn |
| Mar 31, 2025 | 49.32 Mn |
| Dec 31, 2024 | 73.69 Mn |
| Sep 30, 2024 | 58.56 Mn |
| Jun 30, 2024 | 31.11 Mn |
| Mar 31, 2024 | 715,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 469,000.00 |
| Jun 30, 2023 | 238,000.00 |
API Access
Iovance Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();